Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma

Figure 1

LUZP2 expression profile at the mRNA level in the normal and different grade glioma tissues. (a) LUZP2 mRNA expression in different normal human tissues and tumor tissues. LUZP2 mRNA expression in different grade glioma tissues in (b) CGGA and (c) GSE16011. Validation of LUZP2 overexpression for HCC prediction using the ROC curve in (d) TCGA cohort and (e) CGGA cohort.

(a)

(b)

(c)

(d)

(e)